Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-23, Stock:PFE, The news for the past five days is as follows:
2021-11-16: NEWS1: Regulators closer to approving COVID booster for all adults.NEWS2: UPDATE 1-FDA promises quick review of Pfizer booster for all adults, CDC meets Friday.NEWS3: Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill.NEWS4: UPDATE 1-Pfizer files for U.S. authorization of promising COVID-19 antiviral pill.NEWS5: CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine.NEWS6: Pfizer COVID-19 pill set to be 'huge' help in pandemic fight, says doctor.NEWS7: Pfizer Asks FDA To Authorize Its Merck-Rivaling Covid Pill; Shares Inch Down.NEWS8: Pfizer seeks emergency use authorization for its COVID-19 pill.NEWS9: Pfizer Submits Covid-19 Pill for FDA Authorization.NEWS10: Vaccines combatting coronavirus ‘should not be a politicized topic,’ doctor urges.NEWS11: U.S. administers 443.4 mln doses of COVID-19 vaccines - CDC.NEWS12: COVID-19 booster shots are 'going to be the norm,' NewYork-Presbyterian Hospital CEO explains.NEWS13: Pfizer files for U.S. regulatory authorization of its COVID pill.NEWS14: Pfizer files for U.S. authorization of COVID-19 pill.NEWS15: Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate.NEWS16: UPDATE 1-U.S. expected to purchase 10 mln courses of Pfizer COVID-19 pill - WaPo.NEWS17: S&P 500 Closes Just Shy of Record High as Tech, Retailers Shine.NEWS18: Pfizer and Moderna announce moves to help get vital COVID medicines to low-income countries, and Arkansas joins U.S. states expanding booster program to all adults.NEWS19: 4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio.NEWS20: S&P 500 Sets Sights on Record High as Retailers Rally.NEWS21: Pfizer Applies to FDA for Authorization of Anti-Covid Pill.NEWS22: Pfizer Signs Royalty-Free Deal to Aid Poor Nations’ Access to Its Covid Pill.NEWS23: UPDATE 1-Pfizer to allow generic versions of its COVID pill in 95 countries.NEWS24: Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters.NEWS25: UPDATE: Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countries.NEWS26: REFILE-Pfizer to allow generic versions of its COVID-19 pill in 95 countries.NEWS27: Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries.NEWS28: Biden’s Inflation Solution May Be Staring Him in the Face—China.NEWS29: REFILE-Pfizer to conduct trials of antiviral COVID-19 pill in Russia.NEWS30: Walmart, Home Depot Rise Premarket; Tesla, Pfizer Fall.NEWS31: Pfizer Agrees to Allow for Generic Production of Its COVID-19 Pill.NEWS32: Pfizer Falls on Deal With UN-Backed Body to Sell Covid Drug Sans Royalty.
2021-11-17: NEWS1: Why Pfizer Rose While the Market Sank on Wednesday.NEWS2: U.S. administers nearly 445 mln doses of COVID-19 vaccines - CDC.NEWS3: Pfizer Stock Gaps Higher On Covid Pill Enthusiasm — Is It A Buy Now?.NEWS4: 'There will be another pandemic' and we need to be prepared when it comes: Doctor.NEWS5: UPDATE 1-Moderna seeks U.S. authorization of COVID-19 vaccine boosters for all adults.NEWS6: Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise.NEWS7: UK health agency extends gap between infection and shots for children.NEWS8: Pfizer launches search for new CFO as Frank D'Amelio announces his retirement.NEWS9: Atea (AVIR) Plunges on Termination of Collaboration With Roche.NEWS10: Pfizer, EV Stocks, Oil Industry: 3 Things to Watch.NEWS11: Pfizer (PFE) Seeks FDA's Emergency Use Nod for COVID Pill.NEWS12: Are You a Value Investor? This 1 Stock Could Be the Perfect Pick.NEWS13: 3 Big Pharma Outperformers to Watch Out For in the Near Term.NEWS14: Pfizer Files For FDA Emergency Use Nod For Its COVID-19 Antiviral Pill.NEWS15: FDA Plans Quick Review of Pfizer/BioNTech COVID-19 Booster For All Adults: NYT.NEWS16: Pfizer Completes Acquisition of Trillium Therapeutics.NEWS17: UPDATE 2-Pfizer CFO D'Amelio to retire after 15 years at company.NEWS18: Pfizer CFO D'Amelio to retire after 15 years at company.NEWS19: Coronavirus tally: Global cases of COVID-19 above 254.5 million and FDA may authorize boosters for all adults by Thursday.NEWS20: Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio.NEWS21: Nvidia Earnings Are a Big Deal. But There’s Something More Important..NEWS22: Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows.NEWS23: EU watchdog to announce view on vaccine for children next week- Austria.NEWS24: Visa Weighs On Dow, Target Slumps, Lowe's Leaps - Stock Market Live.NEWS25: Target, Visa, Biogen Fall Premarket; Lowe's Rises.NEWS26: Target, Visa, Tesla, Pfizer and Lucid Active, Stocks Steady Amid Inflation Worries.NEWS27: Pfizer Stock Active After CFO Retirement, FDA Application For COVID Pill Approval.NEWS28: Pfizer Gains as Vaccine Booster for All Adults Nears Nod.NEWS29: Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer.NEWS30: Tesla, Pfizer, Visa, Qualcomm & Stock Markets - 5 Things You Must Know.
2021-11-18: NEWS1: UPDATE 1-Canada to authorize use of Pfizer's COVID-19 vaccine for children -source.NEWS2: Pfizer CEO Talks About Covid Vaccines and What Comes Next: ‘I Think We Are Undervalued.’.NEWS3: Why Cardiff Oncology Shares Were Up More Than 15% on Thursday.NEWS4: 'Everyone is a little bit confused' about COVID-19 vaccine mandates and rules: Doctor.NEWS5: Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis.NEWS6: FDA reviews mRNA booster shots for all adults ahead of holiday travel.NEWS7: Face masks and distancing are most effective measures in reducing COVID-19 spread, study finds, as experts clamor for U.S. to expand booster program.NEWS8: Pfizer Again, Macy's, GlobalFoundries: 3 Things to Watch.NEWS9: U.S. Buys 10 Million Treatment Courses of Pfizer’s Covid-19 Pill for $5.29 Billion.NEWS10: Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill.NEWS11: Pfizer to Be Paid $5.29 Billion From U.S. Government for Covid-19 Oral Pill.NEWS12: CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study.NEWS13: EU drug regulator aims to conclude Merck COVID-19 antiviral pill approval by the end of 2021.NEWS14: Italy to acquire 50,000 courses for each of Merck, Pfizer COVID-19 antiviral drugs.NEWS15: Cardiff Oncology Stock Rises After $15M Equity Investment From Pfizer.NEWS16: Pfizer to supply U.S. government with 10 million doses of its antiviral for $5.29 billion.NEWS17: These 3 High-Yield Dividend Stocks Are Growing at Blazing Speeds.NEWS18: CureVac Stock Climbs as Early Data Show Hope for Second Try at Covid Vaccine.NEWS19: The Zacks Analyst Blog Highlights: Eli Lilly, Pfizer and Novo Nordisk.NEWS20: Pfizer seeks emergency U.S. authorization for 10 million doses of new COVID-19 anti viral drug.NEWS21: Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative.NEWS22: UPDATE 5-U.S. to buy 10 mln courses of Pfizer's COVID-19 pill for $5.3 bln.NEWS23: Should Pfizer Investors Expect a Big Dividend Hike in 2022?.NEWS24: Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19.NEWS25: Pfizer Gains on $5.29 Billion Deal with U.S. for Covid-19 Pill.NEWS26: AstraZeneca Says Preventive Covid Antibody Drug Reduces Risk by 83%.NEWS27: Pfizer Stock Gains On $5.3 Billion COVID Pill Treatment Deal With US Government.NEWS28: Companies make progress tackling drug-resistant infections, foundation says.
2021-11-19: NEWS1: CDC recommends COVID-19 vaccine booster shots for all adults.NEWS2: Pfizer-BioNTech, Moderna Covid-19 Boosters for All Adults Backed by FDA, CDC.NEWS3: What Are the Top COVID Plays for 2022?.NEWS4: Pfizer, Moderna Stocks Diverge After FDA Allows Covid Boosters For All Adults.NEWS5: Dow Jones Dips As Apple Drives Higher; Donald Trump SPAC Falls Hard; Nike Runs Into Buy Zone.NEWS6: Oil Prices, Travel Stocks Fall As Covid-19 Continues To Spread, But Hope Is On The Horizon.NEWS7: CDC Advisory Panel Backs Pfizer and Moderna Boosters for All Adults.NEWS8: 'This is wonderful news:' reacting to the CDC's decision to endorse booster shots for adults.NEWS9: CDC panel recommends Moderna, Pfizer booster for all adults.NEWS10: Why These 10 Stocks Are Trending on Friday.NEWS11: Dow Jones Slides While Nasdaq Pops; Covid Vaccine Stocks Rise; This Shipping Stock Is Actionable Now.NEWS12: Stock market news live updates: Dow slides but tech stocks outperform as Europe's COVID struggles rattle markets.NEWS13: Pfizer and Moderna stocks rise on FDA approval of booster shots.NEWS14: 7 Stocks to Buy as America Lifts Its Travel Ban.NEWS15: Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention.NEWS16: 10 Best Blue-Chip Stocks to Buy for Growth and Dividends in 2022.NEWS17: COVID-19 booster shots get FDA OK, as U.S.’s daily death toll holds above 1,000 and cases rise to 6-week high.NEWS18: FDA Gives Authorization to Two COVID-19 Boosters.NEWS19: COVID-19 Booster Shots From Moderna, Pfizer/BioNTech Score FDA Nod All Adults.NEWS20: Pfizer Assigned Outperform Rating by BMO on 'Solid' Fundamentals.NEWS21: UPDATE 1-EU recommends Merck COVID-19 pill for adults at risk of severe illness.NEWS22: Stock Market Mixed On Global Covid Worries; Vaccine Maker Breaks Out Past Buy Point.NEWS23: U.S. looking to broaden access to COVID-19 antiviral pills - WSJ.NEWS24: Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?.NEWS25: Pfizer, Moderna Stocks Jump After FDA Allows Covid Boosters For All Adults.NEWS26: Merck's (MRK) Keytruda Gets Approval for Certain RCC Patients.NEWS27: Pfizer, BioNTech COVID-19 vaccine authorized in Canada for children 5 to 11 years of age.NEWS28: Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium.NEWS29: UPDATE 3-EU advises on Merck COVID pill as reviews rival from Pfizer.NEWS30: UPDATE 3-Canada approves Pfizer's COVID-19 vaccine for children, shipments to start immediately.NEWS31: Pfizer (PFE) Inks $5.3B COVID Pill Supply Deal With U.S..NEWS32: FDA Authorizes Pfizer and Moderna Covid-19 Vaccine Boosters for All Adults.NEWS33: COVID vaccine access: 'The global inequity is absolutely unacceptable,' doctor says.NEWS34: UPDATE 4-FDA expands COVID-19 booster shot authorization to all U.S. adults.NEWS35: U.S. to make COVID-19 booster shots available to anyone 18 or older.NEWS36: Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older.NEWS37: COVID-19 'boosters-for-all' discussion moves to CDC.NEWS38: Will Pfizer and BioNTech Win Authorization for Boosters for All Adults?.NEWS39: Can Moderna Become a $200 Billion Company in 2022?.NEWS40: Pfizer to apply for EU authorization of its COVID pill on Friday - Wirtschaftswoche.NEWS41: Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots.NEWS42: U.S. administers 446.3 mln doses of COVID-19 vaccines - CDC.
2021-11-22: NEWS1: Is Pfizer Stock A Buy After Winning Broad Covid Booster Authorization?.NEWS2: One dose of the J&J COVID-19 vaccine is ‘certainly not enough’: Doctor.NEWS3: REFILE-U.S. administers 452.6 mln doses of COVID-19 vaccines - CDC.NEWS4: Walgreens (WBA) to Offer COVID-19 Vaccine Booster Shots.NEWS5: COVID-19 cases and hospitalizations on the rise ahead of holiday gatherings.NEWS6: FDA Authorizes PFE & MRNA's COVID-19 Boosters for All Adults.NEWS7: Pfizer-BioNTech's COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In Adolescents.NEWS8: UPDATE 1-EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'.NEWS9: Merkel Says Covid Spike ‘Worse Than Anything We’ve Seen’.NEWS10: 3 Healthcare Stocks That Are Too Cheap to Ignore.NEWS11: UPDATE 1-Pfizer's COVID-19 vaccine trial data shows long-term efficacy in adolescents.NEWS12: Pfizer and BioNTech say late-stage trial shows vaccine effective for 12- to 15-year-olds.NEWS13: Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age.NEWS14: 3 No-Brainer Stocks to Buy With $1,000 Right Now.NEWS15: Vaccine-Makers Edge Higher as Regulators OK Boosters for All Adults.NEWS16: S&P 500, Nasdaq Hit Record High, Dow Leaps As Jerome Powell Re-Named Fed Chairman - Stock Market Live.NEWS17: Germany has enough mRNA shots to meet vaccine demand- Spahn.NEWS18: Rivian Falls Premarket; Tesla and Uber Rise.NEWS19: Tesla, Pfizer Active, German COVID Crisis, Inflation in Focus - Stock Market Live.NEWS20: Pfizer Stock Jumps On Follow-Up Data From Adolescent COVID Vaccine Trial.

Answer: Decrease